Bausch Health Companies Inc. ( BHC) - Key Metrics
BHC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.61 | $0.69 | $1.79 | $1.58 |
| 2026Q1 | $6.77 | -$3.82 | $0.62 | $0.22 |
| 2025Q4 | $7.55 | -$0.30 | $1.34 | $1.09 |
| 2025Q3 | $7.22 | $0.48 | $1.09 | $0.85 |
| 2025Q2 | $6.82 | $0.40 | $0.78 | $0.51 |
BHC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 1.84 |
| 2026Q1 | 0% | -0.36 |
| 2025Q4 | 0% | -5.60 |
| 2025Q3 | 0% | 3.36 |
| 2025Q2 | 0% | 4.06 |
BHC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 32.08% | 0% |
| 2026Q1 | 4.12% | 0% |
| 2025Q4 | 15.63% | 0% |
| 2025Q3 | 13.11% | 0% |
| 2025Q2 | 7.69% | 0% |
BHC
Price: $5.80
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.94 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 1.8 million
Market Capitalization: 2.5 billion